Leading children's medic backs national vitamin D drive (Medical News Today, 31 October 2012)
Clinical Questions published as a virtual issue of Clinical Endocrinology

Novartis heart failure drug cuts death by 37 percent: study (Reuters, 7 November 2012)

07 Nov 2012

Results of an international phase III trial of Novartis' RLX030, a recombinant version of the hormone relaxin-2, for treatment of acute heart failure were presented at the American Heart Association (AHA) Scientific Sessions in Los Angeles and published in The Lancet.

Full article

Related Topics

Adrenal Diabetes Metabolism Obesity Cardiovascular Bone Endocrine-Disrupting Chemicals Endocrine-Related Cancer Neuroendocrinology Reproduction Steroid and Steroidogenesis Thyroid

Share this story

Top stories

Call for nominations for Awards Committee Chair
30 Oct 2024

James M Tanner Award - 2025 nominations open
30 Oct 2024

Would you like to host the BSPED annual meeting?
21 Oct 2024

Most read